BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9033255)

  • 1. Aberrant p27kip1 expression in endocrine and other tumors.
    Lloyd RV; Jin L; Qian X; Kulig E
    Am J Pathol; 1997 Feb; 150(2):401-7. PubMed ID: 9033255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
    Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
    Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
    Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
    Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
    Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
    Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
    Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI
    J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
    Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
    J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
    Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
    Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.
    Quintanilla-Martinez L; Thieblemont C; Fend F; Kumar S; Pinyol M; Campo E; Jaffe ES; Raffeld M
    Am J Pathol; 1998 Jul; 153(1):175-82. PubMed ID: 9665478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
    Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
    Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity.
    Jordan RC; Bradley G; Slingerland J
    Am J Pathol; 1998 Feb; 152(2):585-90. PubMed ID: 9466585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of p27/Kip1 is associated with the development of pulmonary adenocarcinoma.
    Hayashi H; Ito T; Yazawa T; Ikeda M; Inayama Y; Nakatani Y; Kameda Y; Nakamura N; Kitamura H
    J Pathol; 2000 Sep; 192(1):26-31. PubMed ID: 10951396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
    Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O
    Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.
    Ciaparrone M; Yamamoto H; Yao Y; Sgambato A; Cattoretti G; Tomita N; Monden T; Rotterdam H; Weinstein IB
    Cancer Res; 1998 Jan; 58(1):114-22. PubMed ID: 9426067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of P27kip1 and Ki-67 in pituitary adenomas: an investigation of marker of adenoma invasiveness.
    Zhao D; Tomono Y; Nose T
    Acta Neurochir (Wien); 1999; 141(2):187-92. PubMed ID: 10189502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
    Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
    Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.